Cargando…

Closure of pulmonary cavity of a multidrug-resistant tuberculosis patient with catheter insertion – A case report

The treatment of multidrug-resistant tuberculosis (MDR-TB) relies heavily on optimal chemotherapy, but interventional therapies can be adopted as adjuvant treatment to speed up illness control and increase the cure rate. We present a case of a 31-year-old MDR-TB male patient with a massive pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peize, Cao, Weipeng, Ye, Taosheng, Deng, Guofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997894/ https://www.ncbi.nlm.nih.gov/pubmed/32042929 http://dx.doi.org/10.1016/j.jctube.2020.100146

Ejemplares similares

Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities
por: Zhang, Peize, et al.
Publicado: (2020)

Pediatric isoniazid-resistant tuberculosis of the bone marrow manifesting as hemophagocytic syndrome: A case report
por: Zheng, Junfeng, et al.
Publicado: (2022)

The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection
por: Yang, Qianting, et al.
Publicado: (2023)

Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing
por: Dheda, Keertan, et al.
Publicado: (2019)

Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study
por: Zhan, Senlin, et al.
Publicado: (2022)

Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report
por: He, Wan, et al.
Publicado: (2018)

Pharmacokinetics of Antituberculosis Drugs in Plasma and Cerebrospinal Fluid in a Patient with Pre-Extensive Drug Resistant Tuberculosis Meningitis
por: Liang, Zhilin, et al.
Publicado: (2023)

Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
por: Zou, Jin, et al.
Publicado: (2022)

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
por: Fu, Liang, et al.
Publicado: (2023)

Endobronchial Valve Treatment of Tuberculous Cavities in Patients with Multidrug-Resistant Pulmonary Tuberculosis: A Randomized Clinical Study
por: An, Huiru, et al.
Publicado: (2022)

Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
por: Shim, Tae Sun, et al.
Publicado: (2013)

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China
por: Yuan, Xiaoliang, et al.
Publicado: (2013)

Sleep quality and influencing factors and correlation with T-lymphocyte subpopulation counts in patients with pulmonary tuberculosis: a cross-sectional study
por: Zhang, Hailin, et al.
Publicado: (2022)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022)

Mycobacterium tuberculosis Utilizes Host Histamine Receptor H1 to Modulate Reactive Oxygen Species Production and Phagosome Maturation via the p38MAPK-NOX2 Axis
por: Mo, Siwei, et al.
Publicado: (2022)

Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment
por: Singla, Rupak, et al.
Publicado: (2018)

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis
por: Liang, Juan, et al.
Publicado: (2021)

A cross-sectional study: a breathomics based pulmonary tuberculosis detection method
por: Fu, Liang, et al.
Publicado: (2023)

Central venous catheter-related bloodstream infection and colonization: the impact of insertion site and distribution of multidrug-resistant pathogens
por: Pitiriga, Vassiliki, et al.
Publicado: (2020)

Clinical Evaluation of Active Tuberculosis-Related Deaths in Shenzhen, China: A Descriptive Study
por: Zhang, Peize, et al.
Publicado: (2021)

Factors Associated with Medical Follow-Up Adherence for Patients on All-Oral Regimen for Multidrug-Resistant Tuberculosis in Shenzhen, China
por: Li, Hui, et al.
Publicado: (2021)

Multidrug-resistant Tuberculosis Lymphadenitis as the Initial Presentation of Secondary Multidrug-resistant Tuberculosis: A Case Report
por: Ogundipe, Temitayo, et al.
Publicado: (2018)

Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients
por: Sharma, Surendra K., et al.
Publicado: (2011)

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
por: Bernard, Christine, et al.
Publicado: (2014)

Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis
por: Deshkar, Anuradha T, et al.
Publicado: (2022)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Cycloserine-Induced Insomnia and Psychosis in Multidrug-Resistant Pulmonary Tuberculosis - A Case Report
por: Yadav, Sankalp
Publicado: (2022)

Multidrug-resistant tuberculosis in middle ear: A case report
por: Cao, Tanze, et al.
Publicado: (2023)

Duration and Determinants of Delayed Diagnosis with Tuberculosis in Shenzhen, China: A Cross-Sectional Study
por: Jiang, Youli, et al.
Publicado: (2022)

Closures of Cavities in Bones
Publicado: (1919)

Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study
por: Zhang, Peize, et al.
Publicado: (2021)

Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Patients with Pulmonary Tuberculosis in Zahedan, Southeastern Iran
por: Metanat, M, et al.
Publicado: (2012)

Transbronchial tuberculosis cavity plugging therapy for pulmonary tuberculosis
por: Han, Junfeng, et al.
Publicado: (2021)

Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis
por: Martínez, Dalila, et al.
Publicado: (2010)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series
por: Wang, Lin, et al.
Publicado: (2017)

Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
por: Wang, Xiaofeng, et al.
Publicado: (2020)

Catheter-related Bacteremia and Multidrug-resistant Acinetobacter lwoffii
por: Tega, Luciano, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_asip8pquvt4e3tbq2b0sj6pcti